|Day Low/High||71.00 / 72.83|
|52 Wk Low/High||64.67 / 92.74|
Negative political pressure is being felt in an overbearing way on the entire healthcare sector.
While the two tobacco giants have similar yields, both also have very different businesses, with different growth potential in the years ahead.
These stocks have grown their dividend for years but the yield has now reached levels of attraction.
Does it not make sense to create a separate portfolio made up of equities that will benefit -- as sick as that sounds -- when an area needs to rebuild?
Any logical evaluation of this stock suggests low risk and tremendous upside.
Any logical evaluation of British American Tobacco suggests low risk and tremendous upside.
Cannabis and tobacco are hard to equate, which Barclays' primer on the Cannabis industry misses.
Each of these names is showing technical bullish or bearish reversal patterns.
It's time for the central bank to show the same level of concern for their misplaced aggression.
There are several avenues to invest in the potential cannabis boom -- recreational plays; medical plays; and companies that have a lot to gain from the industry but aren't reliant upon it for success.
John Butters and his FactSet team noted individual companies that have seen the largest changes in third-quarter earnings forecasts by sector.
Not every cannabis stock was strong on Wednesday. One significant Canadian name sure was though.
The Dow snapped a four-day winning streak as President Trump commented on the Federal Reserve and currency manipulation in an interview that it set to air Friday.
Cloud stocks, unlike most of tech, are less exposed to Chinese revenue and tariffs.
British American Tobacco hasn't been this cheap since 2010.
Fridays are tough because of Chinese retaliation in what's become a hot trade war as the US fights back.
The creature from beneath your bed, or from the darkest recesses of your closet, can still spook the marketplace.
Latest salvo in China trade war damages tech while higher rates and oil undercut consumer goods and housing.
For my portfolio, you can't beat this SBUX competitor -- and for a cup of coffee.
The free market is going to take back control of interest rates.
Former employees told CNBC that the company is having issues producing the batteries for the vehicles.